AVE vs MYX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

53MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

AVE MYX
Technical
52
51
Catalyst
62
53
Sentiment
50
50
Fundamental
49
85
Momentum
75
38
Risk Gate
45
42

Key Metrics

AVE Metric MYX
$77.3MMarket Cap$233.2M
24.9MAvg Volume (20d)291K
N/AShort Interest+2.5%
$0.02752-Week High$6.500
$0.00452-Week Low$2.040
-2.4%Daily Change-0.7%
$0.020Reference Price$2.810
-182.9%ROE-20.6%
N/AProfit Margin-20.4%

Active Signals

AVE Signals

●MACD momentum is losing steam
●Beating the Small Ords index — relative strength of 1.65, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Very high P/S ratio (62.4x)
●Revenue in sharp decline (-17%)
●Small-cap ($20-100M)
●Not enough chatter to gauge sentiment — defaulting to neutral

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

Ask Scout AI to compare AVE and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVE vs NAN →AVE vs NSB →AVE vs NTI →AVE vs NUZ →AVE vs NXN →
AVE Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).